Valuation : Avinger, Inc.

Market Cap 2.71M 2.33M 2.19M 2M 3.74M 256M 3.75M 25.96M 10.04M 131M 10.17M 9.94M 418M P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 12.83M 11.03M 10.38M 9.47M 17.71M 1.21B 17.77M 123M 47.55M 621M 48.17M 47.12M 1.98B EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
3 years 0.36
Extreme 0.363
14
5 years 0.36
Extreme 0.363
288.9
10 years 0.36
Extreme 0.363
618,002.47
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 05/08/2024
Date Insider Type Main position Quantity % Market Cap. Importance
23/1/25 Sell

Founder

2,215 0.0669%
23/1/25 Sell

Chief Financial Officer

1,255 0.0379%
23/1/25 Sell

Chief Executive Officer

3,690 0.1115%
Change 5-day change 1-year change 3-year change Capi.($)
-20.74%-.--%-.--%-92.74% 1.52M
-1.23%+2.62%-24.82%+0.41% 13.06B
+3.57%-4.75%+14.55%+19.89% 4.38B
+3.07%+4.89%-35.60%-51.23% 1.31B
-1.10%-2.62%-37.11%-40.52% 1.13B
-3.63%-3.39%+15.92%+76.32% 1.07B
+1.26%+1.72% - - 1.05B
+0.44%-3.71%-36.93% - 1.03B
+3.52%-2.89%+30.09%+105.28% 521M
+0.34%+2.57%+67.32% - 300M
Average -1.45%+0.96%-0.73%+2.49% 2.38B
Weighted average by Cap. +0.09%+0.21%-14.64%+5.40%

Financials

2022 2023
Net sales 8.27M 7.11M 6.69M 6.11M 11.42M 782M 11.46M 79.34M 30.67M 401M 31.07M 30.39M 1.28B 7.65M 6.58M 6.19M 5.65M 10.57M 724M 10.6M 73.39M 28.37M 371M 28.74M 28.11M 1.18B
Net income -17.62M -15.16M -14.25M -13.01M -24.34M -1.67B -24.41M -169M -65.33M -854M -66.18M -64.73M -2.72B -18.32M -15.76M -14.82M -13.53M -25.3M -1.73B -25.38M -176M -67.91M -887M -68.8M -67.29M -2.83B
Net Debt 1.76M 1.51M 1.42M 1.3M 2.42M 166M 2.43M 16.84M 6.51M 85.05M 6.59M 6.45M 271M 10.12M 8.7M 8.19M 7.47M 13.98M 957M 14.02M 97.06M 37.52M 490M 38M 37.17M 1.56B
Logo Avinger, Inc.
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
70
  1. Stock Market
  2. Stocks
  3. AVGR Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!